How do genetics and ADHD contribute to addiction of susceptibility?

PostedNovember 25, 2025

UpdatedNovember 26, 2025

ByMy Patient Advice

Author: Victoria Rowe, MSc | Reviewed by: Dr. Rebecca Fernandez, MBBS

Growing evidence shows that ADHD and addiction share strong biological foundations. According to NHS England, people with ADHD face a higher risk of substance misuse not just because of the environment, but due to inherited differences in dopamine pathways and impulse regulation. Genetics and ADHD traits often overlap, creating a shared vulnerability.

How genes shape addiction risk

ADHD is one of the most heritable neurodevelopmental conditions. Twin and family research published in PubMed and summarised by the Royal College of Psychiatrists shows that genetic factors account for around 70–80% of ADHD traits. Many of the same genes also influence addiction.

Variants in dopamine-related genes, including DRD2, DRD4, DAT1, and COMT, affect how the brain processes reward and motivation. These variants are linked to impulsivity, sensation-seeking, and reduced dopamine signalling, all of which increase the likelihood of both ADHD symptoms and addictive behaviours (PubMed; PMC).

This overlap helps explain why individuals with ADHD may find substances or stimulating behaviours more rewarding or harder to resist.

When genes interact with the environment

Genetics create vulnerability, but the environment can trigger it. Stress, trauma, peer influence, and early exposure to alcohol or nicotine can escalate the risk, especially in people with ADHD-linked dopamine profiles. Longitudinal studies published in PMC show that these factors can “activate” genetic susceptibility and accelerate the progression from experimentation to addiction.

Family history plays a major role, too. If a parent has ADHD, addiction, or another mental health condition, the likelihood of both ADHD and substance misuse increases (PubMed).

Can treatment reduce genetic risk?

Yes, significantly. According to recent BMJ evidence, ADHD medication is associated with lower long-term risk of substance misuse by improving impulse control, stabilising dopamine activity, and supporting healthier decision-making (BMJ, 2024). NICE guidance also emphasises early diagnosis, psychoeducation, and structured psychological support to buffer both genetic and environmental risk factors (NICE NG87).

NHS pathways, including regional guidance such as NHS Scotland’s ADHD recommendations, now encourage routine screening for addiction risk during assessment, especially in individuals with strong family history.

Programmes offering behavioural and psychoeducational support, including those being developed by Theara Change, can help people develop safer coping strategies and strengthen resilience.

Takeaway

ADHD and addiction share genetic and neurobiological roots, especially within dopamine systems linked to reward and impulse control. But vulnerability is not destiny. Early diagnosis, evidence-based treatment, and supportive environments can dramatically reduce the risk, allowing individuals to understand their biology and take control of their long-term wellbeing.

Victoria Rowe, MSc

Author

Victoria Rowe is a health psychologist with a Master’s in Health Psychology and a BS in Applied Psychology. She has experience as a school psychologist, conducting behavioural assessments, developing individualized education plans (IEPs), and supporting children’s mental health. Dr. Rowe has contributed to peer-reviewed research on mental health, including studies on anxiety disorders and the impact of COVID-19 on healthcare systems. Skilled in SPSS, Minitab, and academic writing, she is committed to advancing psychological knowledge and promoting well-being through evidence-based practice.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Rebecca Fernandez, MBBS

Reviewer

Dr. Rebecca Fernandez is a UK-trained physician with an MBBS and experience in general surgery, cardiology, internal medicine, gynecology, intensive care, and emergency medicine. She has managed critically ill patients, stabilised acute trauma cases, and provided comprehensive inpatient and outpatient care. In psychiatry, Dr. Fernandez has worked with psychotic, mood, anxiety, and substance use disorders, applying evidence-based approaches such as CBT, ACT, and mindfulness-based therapies. Her skills span patient assessment, treatment planning, and the integration of digital health solutions to support mental well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewer's privacy.